Cargando…

Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization

Patients hospitalized with coronavirus disease 2019 (COVID-19) often receive empiric antibiotic coverage. Procalcitonin (PCT) is a biomarker with Food and Drug Administration–approved guidance cutoffs for antibiotic use in lower respiratory tract infections. Herein we describe the implementation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fratoni, Andrew J, Kois, Abigail K, Colmerauer, Jessica L, Linder, Kristin E, Nicolau, David P, Kuti, Joseph L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494375/ https://www.ncbi.nlm.nih.gov/pubmed/36176570 http://dx.doi.org/10.1093/ofid/ofac468

Ejemplares similares

972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO)
por: Fratoni, Andrew J, et al.
Publicado: (2023)

112. Impact of Respiratory Viral PCR Panels (RVP) and Serum Procalcitonin (PCT) on Antibiotic Days of Therapy (DOT) in Patients Admitted with Lower Respiratory Tract Infections (LRTI)
por: Bilinskaya, Anastasia, et al.
Publicado: (2020)

58. Impact of Order-set Modifications and Provider Education on Broad-Spectrum Antibiotic Use in Patients Admitted with Community Acquired Pneumonia
por: Colmerauer, Jessica L, et al.
Publicado: (2021)

1109. Pharmacokinetics and Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
por: Kois, Abigail K, et al.
Publicado: (2021)

65. In Vivo Efficacy of Human Simulated Minocycline (MIN) against Stenotrophomonas maltophilia (STM)
por: Fratoni, Andrew J, et al.
Publicado: (2021)

1103. Minocycline (MIN) Pharmacodynamics (PD) against Stenotrophomonas maltophilia (STM) in a Neutropenic Murine Thigh Infection Model
por: Fratoni, Andrew J, et al.
Publicado: (2021)

1087. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients with Augmented Renal Clearance (ARC)
por: Fratoni, Andrew J, et al.
Publicado: (2021)

Improving Asthma Management: Patient–Pharmacist Partnership Program in Enhancing Therapy Adherence
por: Makhinova, Tatiana, et al.
Publicado: (2022)

Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections
por: Baumann, Philipp, et al.
Publicado: (2017)

Superiority of Transcriptional Profiling Over Procalcitonin for Distinguishing Bacterial From Viral Lower Respiratory Tract Infections in Hospitalized Adults
por: Suarez, Nicolas M., et al.
Publicado: (2015)

Diagnostic Stewardship in Lower Respiratory Tract Infections Using Procalcitonin
por: Gusovsky, Amanda, et al.
Publicado: (2021)

Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis
por: Gill, Christian M, et al.
Publicado: (2022)

1241. In Vivo Efficacy of Meropenem Against Metallo-ß-Lactamase (MBL)-Harboring Pseudomonas aeruginosa and Correlation to In Vitro Susceptibility Upon Addition of EDTA
por: Kois, Abigail K, et al.
Publicado: (2021)

Prognostic value of procalcitonin in respiratory tract infections across clinical settings
por: Kutz, Alexander, et al.
Publicado: (2015)

Prognostic value of procalcitonin in respiratory tract infections across clinical settings
por: Kutz, A, et al.
Publicado: (2015)

Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections
por: Nobre, Vandack, et al.
Publicado: (2016)

Diagnosis of influenza from lower respiratory tract sampling after negative upper respiratory tract sampling
por: Bogoch, Isaac I., et al.
Publicado: (2013)

Procalcitonin levels in salmonella infection
por: Mishra, Vikas, et al.
Publicado: (2015)

Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections
por: Drozdov, Daniel, et al.
Publicado: (2013)

C-reactive protein-guided use of procalcitonin in COVID-19
por: Houghton, Rebecca, et al.
Publicado: (2021)

Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly
por: Ha, Meghan, et al.
Publicado: (2022)

Respiratory tract infection during Hajj
por: Alzeer, Abdulaziz H.
Publicado: (2009)

Continuous Stakeholder Engagement: Expanding the Role of Pharmacists in Prevention of Type 2 Diabetes Through the National Diabetes Prevention Program
por: Ross, Leslie W., et al.
Publicado: (2020)

325. Empiric Antibiotics for COVID-19 and the Utility of Procalcitonin
por: Desens, Adrienne D, et al.
Publicado: (2021)

Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program
por: Dumkow, Lisa E., et al.
Publicado: (2017)

Agreement Between Two Procalcitonin Assays in Hospitalized Children
por: Katz, Sophie E., et al.
Publicado: (2019)

Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection
por: Huang, David T., et al.
Publicado: (2017)

Clinical Correlation of Adenoviral Load in the Respiratory Tract Measured by Digital PCR in Immunocompromised Children
por: Hijano, Diego R, et al.
Publicado: (2023)

Geographic Variability in Diagnosis and Antibiotic Prescribing for Acute Respiratory Tract Infections
por: Hersh, Adam L., et al.
Publicado: (2017)

Antimicrobial Stewardship at Transitions of Care to Outpatient Settings: Synopsis and Strategies
por: Liu, Elaine, et al.
Publicado: (2022)

Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
por: Hughes, Stephen, et al.
Publicado: (2021)

Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study
por: Hartnett, Jessica, et al.
Publicado: (2022)

The role of procalcitonin as a guide for the diagnosis, prognosis, and decision of antibiotic therapy for lower respiratory tract infections
por: El-Azeem, Amal Abd, et al.
Publicado: (2013)

2194. Procalcitonin-Guided Antibiotic Strategy for Lower Respiratory Tract Infections: Outcomes and Safety of Withholding Antibiotics
por: Bambino Geno Tai, Don, et al.
Publicado: (2019)

Understanding the Use of Program Resources During Virtual Recruitment by Psychiatry Residency Applicants
por: Bernstein, Simone A., et al.
Publicado: (2023)

Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes
por: Ko, John J., et al.
Publicado: (2016)

Effect of a Pharmacist-Driven Monitoring Program and Electronic Health Record on Bleeding Log Completeness and Documentation
por: Shay, Blake, et al.
Publicado: (2018)

Utilization of Instagram by Psychiatry Residency Programs in a Virtual Recruitment World
por: Bernstein, Simone A., et al.
Publicado: (2021)

Coinfections of the Respiratory Tract: Viral Competition for Resources
por: Pinky, Lubna, et al.
Publicado: (2016)

Gemykibivirus Genome in Lower Respiratory Tract of Elderly Woman With Unexplained Acute Respiratory Distress Syndrome
por: Wang, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jru4sjkphv6u0vkr13qg7ip7d7